Rebecca Taub

Insider Reports History

Entity
Individual
Location
750 Battery Street, Suite 330, San Francisco, CA
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rebecca Taub:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Pres., R&D, and CMO, Director Common Stock 656K $220M $335.00 Mar 5, 2025 By SQN, LLC
MADRIGAL PHARMACEUTICALS, INC. Pres., R&D, and CMO, Director Common Stock 461K $154M $335.00 Mar 5, 2025 Direct
MADRIGAL PHARMACEUTICALS, INC. Pres., R&D, and CMO, Director Stock Option (Right to Buy) 7.38K Mar 5, 2025 Direct

Insider Reports Filed by Rebecca Taub

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Mar 5, 2025 2 $0 4 Mar 7, 2025 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 24, 2025 1 -$217K 4 Jan 27, 2025 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 17, 2025 1 -$462K 4 Jan 17, 2025 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Apr 8, 2024 8 -$633K 4 Apr 10, 2024 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Apr 3, 2024 25 -$17.3M 4 Apr 5, 2024 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 23, 2024 3 $0 4 Jan 25, 2024 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2024 1 -$377K 4 Jan 18, 2024 Pres., R&D, and CMO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 $0 4 Jan 18, 2023 Pres., R&D, and CMO, Director
BCTX BriaCell Therapeutics Corp. Aug 1, 2022 0 $0 3 Aug 1, 2022 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Medical Officer, President, R&D ** As attorney-in-fact for Reporting Person, Director